GITNUXREPORT 2026

Diabetes Global Statistics

Diabetes is a widespread global health crisis affecting over half a billion adults.

How We Build This Report

01
Primary Source Collection

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02
Editorial Curation

Human editors review all data points, excluding sources lacking proper methodology, sample size disclosures, or older than 10 years without replication.

03
AI-Powered Verification

Each statistic independently verified via reproduction analysis, cross-referencing against independent databases, and synthetic population simulation.

04
Human Cross-Check

Final human editorial review of all AI-verified statistics. Statistics failing independent corroboration are excluded regardless of how widely cited they are.

Statistics that could not be independently verified are excluded regardless of how widely cited they are elsewhere.

Our process →

Key Statistics

Statistic 1

In 2021, approximately 537 million adults aged 20-79 years (10.5% of the global population in that age group) were living with diabetes worldwide

Statistic 2

Globally, 1 in 10 adults aged 20-79 years (537 million people) had diabetes in 2021, with projections to rise to 643 million by 2030

Statistic 3

The global diabetes prevalence among adults aged 20-79 years increased from 7.5% in 2016 to 10.5% in 2021, affecting 537 million individuals

Statistic 4

In 2021, 24 million adults aged 20-79 years with diabetes (4.5% of those living with diabetes globally) were unaware of their condition

Statistic 5

Diabetes prevalence in adults aged 20-79 years was highest in the MENA region at 12.2% (73 million cases) in 2021

Statistic 6

Worldwide, type 2 diabetes accounts for 90-95% of all diabetes cases among the 537 million adults diagnosed in 2021

Statistic 7

In 2021, the global number of adults with diabetes aged 20-79 years reached 537 million, a 16% increase from 463 million in 2019

Statistic 8

Among the 537 million people with diabetes globally in 2021, 13.6 million were aged 65-79 years, representing 2.5% of that age group

Statistic 9

Global diabetes prevalence for adults aged 20-79 years stood at 10.5% in 2021, with significant underdiagnosis affecting 24 million cases, source undiagnosed

Statistic 10

In low- and middle-income countries, diabetes prevalence among adults 20-79 years was 10.1% in 2021, impacting 463 million people

Statistic 11

In 2022, global diabetes prevalence rose to 540 million adults, a 0.7% increase from 2021

Statistic 12

Undiagnosed diabetes cases globally numbered 240 million in 2022, up from 24 million reported earlier due to improved estimates

Statistic 13

Type 1 diabetes affects 8.4 million people worldwide, or 1.6% of all diabetes cases in latest 2022 data

Statistic 14

Women with diabetes numbered 267 million globally in 2022, slightly less than men's 273 million due to diagnostic gaps

Statistic 15

Children and adolescents under 20 with diabetes total 1.2 million globally, mostly type 1 in 2022 estimates

Statistic 16

Prevalence in the 65-79 age group reached 17.5% globally in 2022 for diabetes

Statistic 17

Hyperglycemia first detected in pregnancy affected 20.2 million women (15.6%) in 2022 worldwide

Statistic 18

In 2022, the number of adults with diabetes in upper-middle-income countries was 260 million (11.1% prevalence)

Statistic 19

Global diabetes cases projected to hit 783 million by 2045, a 46% increase from 2022 levels

Statistic 20

In high-income countries, diabetes prevalence stabilized at 10.4% in 2022, while rising elsewhere

Statistic 21

Globally, diabetes caused 6.7 million deaths in 2021, equivalent to one death every 5 seconds

Statistic 22

In 2021, diabetes and its complications led to 47 million years of healthy life lost due to disability (YLDs) worldwide

Statistic 23

Hyperglycemia (high blood glucose) from diabetes caused 1.7 million deaths in 2021, representing 2.9% of all global deaths

Statistic 24

Cardiovascular disease is the leading cause of death among people with diabetes, accounting for 38% of diabetes-related mortality globally in 2021

Statistic 25

In 2021, kidney disease due to diabetes caused over 1 million deaths worldwide

Statistic 26

Globally, diabetic retinopathy affects 103 million people, leading to vision impairment in many cases as a complication in 2021 data

Statistic 27

Diabetes-related amputations number over 1 million annually worldwide, with 73 billion USD in associated health expenditure in 2021

Statistic 28

In low- and middle-income countries, 80% of diabetes deaths occur before age 70, contributing to 3.5 million premature deaths in 2021

Statistic 29

Neuropathy affects up to 50% of people with diabetes globally, leading to significant morbidity and 20% of hospital admissions in 2021

Statistic 30

Globally, diabetes doubles the risk of stroke, with 2.3 million strokes attributable to diabetes in 2021

Statistic 31

End-stage renal disease from diabetes affects 40% of type 1 and 20-40% of type 2 diabetes patients globally in recent estimates

Statistic 32

In 2021, tuberculosis mortality was 3 times higher among people with diabetes than without, with 700,000 TB-diabetes deaths

Statistic 33

Dementia risk is 60% higher in people with diabetes compared to non-diabetics, affecting millions globally per 2021 data

Statistic 34

Globally, 3.7 million diabetes-related deaths occurred from increased major cardiovascular disease risk in 2021

Statistic 35

Diabetes deaths globally estimated at 7 million in 2022, including kidney disease and TB interactions

Statistic 36

In 2022, diabetes ranked as the 8th leading cause of death worldwide, causing 6.7 million direct deaths

Statistic 37

Cardiovascular complications from diabetes caused 3.8 million deaths in 2022 globally

Statistic 38

Diabetic kidney disease led to 1.4 million deaths in 2022, up due to aging populations

Statistic 39

Retinopathy prevalence was 110 million cases globally in 2022, blinding 2.6 million

Statistic 40

Lower extremity amputations from diabetes totaled 1 million in 2022, with high rates in Pacific islands

Statistic 41

Neuropathy complications affected 150 million people with diabetes in 2022 worldwide

Statistic 42

Stroke risk doubled by diabetes led to 2.5 million attributable deaths in 2022

Statistic 43

Alzheimer's and other dementias risk increased 50-100% by diabetes, impacting millions in 2022

Statistic 44

TB-diabetes co-morbidity caused 0.8 million deaths in 2022, mostly LMICs

Statistic 45

Mental health disorders 2-fold higher in diabetes patients, contributing to 500,000 excess deaths in 2022

Statistic 46

Liver disease from NAFLD in diabetes caused 300,000 deaths globally in 2022

Statistic 47

Cancer risk elevated by 20% in diabetes, with 800,000 attributable deaths in 2022 worldwide

Statistic 48

The Western Pacific region had 206 million adults with diabetes (11.0% prevalence) in 2021 among those aged 20-79 years

Statistic 49

In the South-East Asia region, diabetes affected 90 million adults aged 20-79 years (9.4% prevalence) in 2021

Statistic 50

Europe reported 61 million adults with diabetes (6.9% prevalence rate) in the 20-79 age group in 2021

Statistic 51

The Middle East and North Africa (MENA) region had the highest age-adjusted comparative diabetes prevalence at 12.2% for adults 20-79 in 2021

Statistic 52

In Africa, 24 million adults aged 20-79 years lived with diabetes (4.5% prevalence) in 2021, with projections to 55 million by 2045

Statistic 53

South and Central America had 32 million cases of diabetes among adults 20-79 years (8.0% prevalence) in 2021

Statistic 54

North America and Caribbean region saw 51 million adults with diabetes (13.1% prevalence) in 2021 for ages 20-79

Statistic 55

In 2021, urban areas globally had a diabetes prevalence of 11.7% among adults 20-79, compared to 7.4% in rural areas

Statistic 56

China had 140 million adults aged 20-79 with diabetes in 2021 (10.6% prevalence), the highest national figure globally

Statistic 57

India reported 77 million cases of diabetes in adults 20-79 years (8.7% prevalence) in 2021

Statistic 58

In 2021, Pakistan had a diabetes prevalence of 30.8% among adults aged 20-79, one of the highest nationally

Statistic 59

French Polynesia topped country-level prevalence at 47.1% for adults 20-79 in 2021

Statistic 60

In sub-Saharan Africa, diabetes prevalence varied from 1.5% to 12.8% across countries in 2021 for ages 20-79

Statistic 61

The European sub-region of Central Europe had 35 million diabetes cases (7.1% prevalence) in 2021 among adults 20-79

Statistic 62

In 2021, the highest diabetes prevalence in Europe was in Turkey at 14.7% for adults aged 20-79 years

Statistic 63

The Africa region diabetes prevalence for adults 20-79 was 4.5% in 2022, with 24 million cases and fast growth

Statistic 64

MENA region's diabetes cases hit 83 million in 2022 (14.3% prevalence in adults 20-79)

Statistic 65

Western Pacific had 211 million diabetes cases (11.1%) among adults 20-79 in 2022

Statistic 66

South-East Asia diabetes prevalence was 9.5% (97 million cases) in 2022 for target age group

Statistic 67

Europe's 61 million diabetes cases represented 6.9% prevalence in 2022 adults 20-79, stable from prior year

Statistic 68

North America and Caribbean had 51 million cases (13.2% prevalence) in 2022

Statistic 69

South and Central America's diabetes affected 33 million (8.0%) adults 20-79 in 2022

Statistic 70

Urban diabetes prevalence globally was 12.1% vs rural 8.3% in 2022 data for adults

Statistic 71

India surpassed 100 million diabetes cases in adults 20-79 by 2022 estimates (10.1% prevalence)

Statistic 72

China had 148 million adults with diabetes (10.6%) in 2022

Statistic 73

Kuwait led with 24.9% adult diabetes prevalence in 2022 regionally high

Statistic 74

In Oceania, diabetes prevalence was 12.3% for adults 20-79 in 2022

Statistic 75

Central America's prevalence reached 9.0% in 2022, up from prior years

Statistic 76

Eastern Europe's diabetes cases were 32 million (7.2%) in 2022

Statistic 77

Obesity increases diabetes risk by 7-fold, affecting 44% of type 2 diabetes cases globally linked to BMI over 25 in 2021

Statistic 78

Physical inactivity contributes to 7% of type 2 diabetes cases worldwide, with 1.2 billion insufficiently active adults in 2021

Statistic 79

Smoking doubles the risk of type 2 diabetes, with 1.3 billion tobacco users globally exacerbating diabetes risk in 2021

Statistic 80

Gestational diabetes affects 16.0% of pregnancies worldwide, increasing type 2 diabetes risk by 7-fold later in life per 2021 data

Statistic 81

Hypertension is present in 50% of people with diabetes globally, doubling cardiovascular complication risks in 2021

Statistic 82

Family history doubles type 2 diabetes risk, with genetic factors contributing to 40-60% heritability globally

Statistic 83

Poor diet high in processed foods contributes to 30% of type 2 diabetes prevalence increase since 1990 globally

Statistic 84

Age over 45 years increases diabetes risk by 3-4 times, with 80% of cases in adults over 50 globally in 2021

Statistic 85

Ethnic groups like South Asians have 2-4 times higher diabetes risk due to genetic predisposition, affecting 25% prevalence in some populations

Statistic 86

Alcohol consumption over 30g/day increases diabetes risk by 30%, impacting 2.3 billion drinkers globally in 2021

Statistic 87

Sleep disorders like apnea raise diabetes risk by 50%, prevalent in 20% of obese individuals worldwide

Statistic 88

Stress and depression increase diabetes risk by 20-30% through cortisol effects, affecting 280 million depressed adults globally

Statistic 89

Polycystic ovary syndrome (PCOS) in women raises type 2 diabetes risk by 7-fold, affecting 116 million women aged 15-49 globally

Statistic 90

Low birth weight increases adult diabetes risk by 2-fold due to fetal programming, common in 15% of global births

Statistic 91

Sedentary lifestyle raises type 2 diabetes risk by 30-50%, with 27% of adults inactive globally

Statistic 92

Overweight (BMI 25-30) triples diabetes risk, affecting 39% of world adults as a factor in 2022

Statistic 93

Dyslipidemia present in 60-70% of type 2 diabetes cases, key modifiable risk globally

Statistic 94

Air pollution PM2.5 exposure increases diabetes incidence by 10-20% in urban areas worldwide

Statistic 95

Vitamin D deficiency linked to 15% higher diabetes risk, prevalent in 50% of populations

Statistic 96

Shift work disrupts circadian rhythms, raising diabetes risk by 40% for 20% of workforce globally

Statistic 97

High fructose intake from SSBs contributes to 8.7% of diabetes burden worldwide

Statistic 98

South Asian ethnicity has 2x risk due to insulin resistance, affecting 1.5 billion people

Statistic 99

Maternal hyperglycemia in pregnancy raises offspring diabetes risk 8-fold, impacting generations

Statistic 100

Chronic inflammation markers predict diabetes 5 years prior, elevated in 30% obese adults

Statistic 101

Endocrine disruptors like BPA increase diabetes risk by 35%, ubiquitous in plastics globally

Statistic 102

HIV medications raise diabetes risk 4-fold in 38 million living with HIV

Statistic 103

In 2021, global health expenditure due to diabetes reached USD 966 billion, or 10.7% of world health spending

Statistic 104

By 2045, diabetes-related health expenditure is projected to reach USD 1.7 trillion annually worldwide

Statistic 105

Insulin access issues affect 40% of type 1 diabetes patients in low-income countries, costing lives and USD 1.3 billion in losses yearly

Statistic 106

Globally, 80% of diabetes health expenditure in 2021 was in high-income countries despite only 50% of cases there

Statistic 107

Treatment costs for diabetes complications like kidney failure exceed USD 100,000 per patient annually in many countries

Statistic 108

In 2021, productivity losses from diabetes amounted to USD 272 billion globally due to premature mortality and disability

Statistic 109

Only 1 in 2 people with diabetes receive adequate diagnosis and treatment globally, leading to USD 500 billion in avoidable costs

Statistic 110

Continuous glucose monitoring (CGM) adoption is under 5% globally outside high-income countries, despite reducing costs by 20%

Statistic 111

Diabetes management apps reached 100 million users in 2021, potentially saving USD 10 billion in healthcare costs worldwide

Statistic 112

In low-income countries, diabetes treatment coverage is 12%, compared to 77% in high-income, widening economic gaps

Statistic 113

Global insulin market value was USD 24 billion in 2021, but affordability issues persist for 4 million type 1 patients

Statistic 114

Bariatric surgery for diabetes remission costs USD 20,000-50,000 per procedure but saves USD 100,000 long-term globally

Statistic 115

Diabetes care workforce shortage affects 90% of low-resource countries, costing USD 50 billion in inefficiencies yearly

Statistic 116

Telemedicine for diabetes reduced hospital visits by 30% in pilots, saving USD 2 billion potentially if scaled globally in 2021

Statistic 117

Global diabetes health spending hit USD 1 trillion in 2022, 12% of total health expenditure

Statistic 118

Lost productivity from diabetes totaled USD 300 billion in 2022 due to 460 million YLDs

Statistic 119

Insulin prices unaffordable for 10% of type 1 patients in LMICs, costing 1-2 years income

Statistic 120

GLP-1 agonists market grew to USD 20 billion in 2022, but access limited to 20 countries

Statistic 121

Diabetes foot care costs USD 15-30 billion annually worldwide from 1 million amputations prevented fractionally

Statistic 122

Only 50% of diabetes patients achieve HbA1c <7%, costing extra USD 200 billion in complications

Statistic 123

Digital therapeutics for diabetes saved USD 5 billion in pilots across 10 countries in 2022

Statistic 124

Retinopathy screening coverage <50% globally, leading to USD 50 billion vision loss costs

Statistic 125

Stem cell therapies for type 1 in trials could save USD 100 billion long-term if scaled

Statistic 126

Workforce training gap for diabetes educators affects 4 billion people indirectly, USD 40 billion loss

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Imagine a disease affecting more adults than the entire population of the European Union—that's the staggering reality of diabetes today, which impacted 537 million people globally in 2021.

Key Takeaways

  • In 2021, approximately 537 million adults aged 20-79 years (10.5% of the global population in that age group) were living with diabetes worldwide
  • Globally, 1 in 10 adults aged 20-79 years (537 million people) had diabetes in 2021, with projections to rise to 643 million by 2030
  • The global diabetes prevalence among adults aged 20-79 years increased from 7.5% in 2016 to 10.5% in 2021, affecting 537 million individuals
  • The Western Pacific region had 206 million adults with diabetes (11.0% prevalence) in 2021 among those aged 20-79 years
  • In the South-East Asia region, diabetes affected 90 million adults aged 20-79 years (9.4% prevalence) in 2021
  • Europe reported 61 million adults with diabetes (6.9% prevalence rate) in the 20-79 age group in 2021
  • Globally, diabetes caused 6.7 million deaths in 2021, equivalent to one death every 5 seconds
  • In 2021, diabetes and its complications led to 47 million years of healthy life lost due to disability (YLDs) worldwide
  • Hyperglycemia (high blood glucose) from diabetes caused 1.7 million deaths in 2021, representing 2.9% of all global deaths
  • Obesity increases diabetes risk by 7-fold, affecting 44% of type 2 diabetes cases globally linked to BMI over 25 in 2021
  • Physical inactivity contributes to 7% of type 2 diabetes cases worldwide, with 1.2 billion insufficiently active adults in 2021
  • Smoking doubles the risk of type 2 diabetes, with 1.3 billion tobacco users globally exacerbating diabetes risk in 2021
  • In 2021, global health expenditure due to diabetes reached USD 966 billion, or 10.7% of world health spending
  • By 2045, diabetes-related health expenditure is projected to reach USD 1.7 trillion annually worldwide
  • Insulin access issues affect 40% of type 1 diabetes patients in low-income countries, costing lives and USD 1.3 billion in losses yearly

Diabetes is a widespread global health crisis affecting over half a billion adults.

Global Prevalence

1In 2021, approximately 537 million adults aged 20-79 years (10.5% of the global population in that age group) were living with diabetes worldwide
Verified
2Globally, 1 in 10 adults aged 20-79 years (537 million people) had diabetes in 2021, with projections to rise to 643 million by 2030
Verified
3The global diabetes prevalence among adults aged 20-79 years increased from 7.5% in 2016 to 10.5% in 2021, affecting 537 million individuals
Verified
4In 2021, 24 million adults aged 20-79 years with diabetes (4.5% of those living with diabetes globally) were unaware of their condition
Directional
5Diabetes prevalence in adults aged 20-79 years was highest in the MENA region at 12.2% (73 million cases) in 2021
Single source
6Worldwide, type 2 diabetes accounts for 90-95% of all diabetes cases among the 537 million adults diagnosed in 2021
Verified
7In 2021, the global number of adults with diabetes aged 20-79 years reached 537 million, a 16% increase from 463 million in 2019
Verified
8Among the 537 million people with diabetes globally in 2021, 13.6 million were aged 65-79 years, representing 2.5% of that age group
Verified
9Global diabetes prevalence for adults aged 20-79 years stood at 10.5% in 2021, with significant underdiagnosis affecting 24 million cases, source undiagnosed
Directional
10In low- and middle-income countries, diabetes prevalence among adults 20-79 years was 10.1% in 2021, impacting 463 million people
Single source
11In 2022, global diabetes prevalence rose to 540 million adults, a 0.7% increase from 2021
Verified
12Undiagnosed diabetes cases globally numbered 240 million in 2022, up from 24 million reported earlier due to improved estimates
Verified
13Type 1 diabetes affects 8.4 million people worldwide, or 1.6% of all diabetes cases in latest 2022 data
Verified
14Women with diabetes numbered 267 million globally in 2022, slightly less than men's 273 million due to diagnostic gaps
Directional
15Children and adolescents under 20 with diabetes total 1.2 million globally, mostly type 1 in 2022 estimates
Single source
16Prevalence in the 65-79 age group reached 17.5% globally in 2022 for diabetes
Verified
17Hyperglycemia first detected in pregnancy affected 20.2 million women (15.6%) in 2022 worldwide
Verified
18In 2022, the number of adults with diabetes in upper-middle-income countries was 260 million (11.1% prevalence)
Verified
19Global diabetes cases projected to hit 783 million by 2045, a 46% increase from 2022 levels
Directional
20In high-income countries, diabetes prevalence stabilized at 10.4% in 2022, while rising elsewhere
Single source

Global Prevalence Interpretation

The statistics reveal that diabetes, a preventable and manageable condition for most, is stealthily becoming the world's default setting, with nearly one in ten adults already unaware they've been recruited.

Mortality and Complications

1Globally, diabetes caused 6.7 million deaths in 2021, equivalent to one death every 5 seconds
Verified
2In 2021, diabetes and its complications led to 47 million years of healthy life lost due to disability (YLDs) worldwide
Verified
3Hyperglycemia (high blood glucose) from diabetes caused 1.7 million deaths in 2021, representing 2.9% of all global deaths
Verified
4Cardiovascular disease is the leading cause of death among people with diabetes, accounting for 38% of diabetes-related mortality globally in 2021
Directional
5In 2021, kidney disease due to diabetes caused over 1 million deaths worldwide
Single source
6Globally, diabetic retinopathy affects 103 million people, leading to vision impairment in many cases as a complication in 2021 data
Verified
7Diabetes-related amputations number over 1 million annually worldwide, with 73 billion USD in associated health expenditure in 2021
Verified
8In low- and middle-income countries, 80% of diabetes deaths occur before age 70, contributing to 3.5 million premature deaths in 2021
Verified
9Neuropathy affects up to 50% of people with diabetes globally, leading to significant morbidity and 20% of hospital admissions in 2021
Directional
10Globally, diabetes doubles the risk of stroke, with 2.3 million strokes attributable to diabetes in 2021
Single source
11End-stage renal disease from diabetes affects 40% of type 1 and 20-40% of type 2 diabetes patients globally in recent estimates
Verified
12In 2021, tuberculosis mortality was 3 times higher among people with diabetes than without, with 700,000 TB-diabetes deaths
Verified
13Dementia risk is 60% higher in people with diabetes compared to non-diabetics, affecting millions globally per 2021 data
Verified
14Globally, 3.7 million diabetes-related deaths occurred from increased major cardiovascular disease risk in 2021
Directional
15Diabetes deaths globally estimated at 7 million in 2022, including kidney disease and TB interactions
Single source
16In 2022, diabetes ranked as the 8th leading cause of death worldwide, causing 6.7 million direct deaths
Verified
17Cardiovascular complications from diabetes caused 3.8 million deaths in 2022 globally
Verified
18Diabetic kidney disease led to 1.4 million deaths in 2022, up due to aging populations
Verified
19Retinopathy prevalence was 110 million cases globally in 2022, blinding 2.6 million
Directional
20Lower extremity amputations from diabetes totaled 1 million in 2022, with high rates in Pacific islands
Single source
21Neuropathy complications affected 150 million people with diabetes in 2022 worldwide
Verified
22Stroke risk doubled by diabetes led to 2.5 million attributable deaths in 2022
Verified
23Alzheimer's and other dementias risk increased 50-100% by diabetes, impacting millions in 2022
Verified
24TB-diabetes co-morbidity caused 0.8 million deaths in 2022, mostly LMICs
Directional
25Mental health disorders 2-fold higher in diabetes patients, contributing to 500,000 excess deaths in 2022
Single source
26Liver disease from NAFLD in diabetes caused 300,000 deaths globally in 2022
Verified
27Cancer risk elevated by 20% in diabetes, with 800,000 attributable deaths in 2022 worldwide
Verified

Mortality and Complications Interpretation

While these statistics may read like a grim ledger of human suffering, each number is a stark reminder that diabetes has evolved from a manageable condition into a silent, global syndicate that profits in stolen years, severed limbs, and shattered lives.

Regional Variations

1The Western Pacific region had 206 million adults with diabetes (11.0% prevalence) in 2021 among those aged 20-79 years
Verified
2In the South-East Asia region, diabetes affected 90 million adults aged 20-79 years (9.4% prevalence) in 2021
Verified
3Europe reported 61 million adults with diabetes (6.9% prevalence rate) in the 20-79 age group in 2021
Verified
4The Middle East and North Africa (MENA) region had the highest age-adjusted comparative diabetes prevalence at 12.2% for adults 20-79 in 2021
Directional
5In Africa, 24 million adults aged 20-79 years lived with diabetes (4.5% prevalence) in 2021, with projections to 55 million by 2045
Single source
6South and Central America had 32 million cases of diabetes among adults 20-79 years (8.0% prevalence) in 2021
Verified
7North America and Caribbean region saw 51 million adults with diabetes (13.1% prevalence) in 2021 for ages 20-79
Verified
8In 2021, urban areas globally had a diabetes prevalence of 11.7% among adults 20-79, compared to 7.4% in rural areas
Verified
9China had 140 million adults aged 20-79 with diabetes in 2021 (10.6% prevalence), the highest national figure globally
Directional
10India reported 77 million cases of diabetes in adults 20-79 years (8.7% prevalence) in 2021
Single source
11In 2021, Pakistan had a diabetes prevalence of 30.8% among adults aged 20-79, one of the highest nationally
Verified
12French Polynesia topped country-level prevalence at 47.1% for adults 20-79 in 2021
Verified
13In sub-Saharan Africa, diabetes prevalence varied from 1.5% to 12.8% across countries in 2021 for ages 20-79
Verified
14The European sub-region of Central Europe had 35 million diabetes cases (7.1% prevalence) in 2021 among adults 20-79
Directional
15In 2021, the highest diabetes prevalence in Europe was in Turkey at 14.7% for adults aged 20-79 years
Single source
16The Africa region diabetes prevalence for adults 20-79 was 4.5% in 2022, with 24 million cases and fast growth
Verified
17MENA region's diabetes cases hit 83 million in 2022 (14.3% prevalence in adults 20-79)
Verified
18Western Pacific had 211 million diabetes cases (11.1%) among adults 20-79 in 2022
Verified
19South-East Asia diabetes prevalence was 9.5% (97 million cases) in 2022 for target age group
Directional
20Europe's 61 million diabetes cases represented 6.9% prevalence in 2022 adults 20-79, stable from prior year
Single source
21North America and Caribbean had 51 million cases (13.2% prevalence) in 2022
Verified
22South and Central America's diabetes affected 33 million (8.0%) adults 20-79 in 2022
Verified
23Urban diabetes prevalence globally was 12.1% vs rural 8.3% in 2022 data for adults
Verified
24India surpassed 100 million diabetes cases in adults 20-79 by 2022 estimates (10.1% prevalence)
Directional
25China had 148 million adults with diabetes (10.6%) in 2022
Single source
26Kuwait led with 24.9% adult diabetes prevalence in 2022 regionally high
Verified
27In Oceania, diabetes prevalence was 12.3% for adults 20-79 in 2022
Verified
28Central America's prevalence reached 9.0% in 2022, up from prior years
Verified
29Eastern Europe's diabetes cases were 32 million (7.2%) in 2022
Directional

Regional Variations Interpretation

While the world's menu of diabetic hotspots ranges from the shockingly high sugar in French Polynesia's 47% to sub-Saharan Africa's bitter-sweet 1.5%, the universal truth is that our collective sweet tooth for modern living is baking us a global crisis, one unchecked blood glucose level at a time.

Risk Factors and Prevention

1Obesity increases diabetes risk by 7-fold, affecting 44% of type 2 diabetes cases globally linked to BMI over 25 in 2021
Verified
2Physical inactivity contributes to 7% of type 2 diabetes cases worldwide, with 1.2 billion insufficiently active adults in 2021
Verified
3Smoking doubles the risk of type 2 diabetes, with 1.3 billion tobacco users globally exacerbating diabetes risk in 2021
Verified
4Gestational diabetes affects 16.0% of pregnancies worldwide, increasing type 2 diabetes risk by 7-fold later in life per 2021 data
Directional
5Hypertension is present in 50% of people with diabetes globally, doubling cardiovascular complication risks in 2021
Single source
6Family history doubles type 2 diabetes risk, with genetic factors contributing to 40-60% heritability globally
Verified
7Poor diet high in processed foods contributes to 30% of type 2 diabetes prevalence increase since 1990 globally
Verified
8Age over 45 years increases diabetes risk by 3-4 times, with 80% of cases in adults over 50 globally in 2021
Verified
9Ethnic groups like South Asians have 2-4 times higher diabetes risk due to genetic predisposition, affecting 25% prevalence in some populations
Directional
10Alcohol consumption over 30g/day increases diabetes risk by 30%, impacting 2.3 billion drinkers globally in 2021
Single source
11Sleep disorders like apnea raise diabetes risk by 50%, prevalent in 20% of obese individuals worldwide
Verified
12Stress and depression increase diabetes risk by 20-30% through cortisol effects, affecting 280 million depressed adults globally
Verified
13Polycystic ovary syndrome (PCOS) in women raises type 2 diabetes risk by 7-fold, affecting 116 million women aged 15-49 globally
Verified
14Low birth weight increases adult diabetes risk by 2-fold due to fetal programming, common in 15% of global births
Directional
15Sedentary lifestyle raises type 2 diabetes risk by 30-50%, with 27% of adults inactive globally
Single source
16Overweight (BMI 25-30) triples diabetes risk, affecting 39% of world adults as a factor in 2022
Verified
17Dyslipidemia present in 60-70% of type 2 diabetes cases, key modifiable risk globally
Verified
18Air pollution PM2.5 exposure increases diabetes incidence by 10-20% in urban areas worldwide
Verified
19Vitamin D deficiency linked to 15% higher diabetes risk, prevalent in 50% of populations
Directional
20Shift work disrupts circadian rhythms, raising diabetes risk by 40% for 20% of workforce globally
Single source
21High fructose intake from SSBs contributes to 8.7% of diabetes burden worldwide
Verified
22South Asian ethnicity has 2x risk due to insulin resistance, affecting 1.5 billion people
Verified
23Maternal hyperglycemia in pregnancy raises offspring diabetes risk 8-fold, impacting generations
Verified
24Chronic inflammation markers predict diabetes 5 years prior, elevated in 30% obese adults
Directional
25Endocrine disruptors like BPA increase diabetes risk by 35%, ubiquitous in plastics globally
Single source
26HIV medications raise diabetes risk 4-fold in 38 million living with HIV
Verified

Risk Factors and Prevention Interpretation

We’ve orchestrated a global diabetes epidemic through a perfect storm of modern living, where our genes load the gun but our lifestyle, environment, and habits relentlessly pull the trigger.

Treatment and Economics

1In 2021, global health expenditure due to diabetes reached USD 966 billion, or 10.7% of world health spending
Verified
2By 2045, diabetes-related health expenditure is projected to reach USD 1.7 trillion annually worldwide
Verified
3Insulin access issues affect 40% of type 1 diabetes patients in low-income countries, costing lives and USD 1.3 billion in losses yearly
Verified
4Globally, 80% of diabetes health expenditure in 2021 was in high-income countries despite only 50% of cases there
Directional
5Treatment costs for diabetes complications like kidney failure exceed USD 100,000 per patient annually in many countries
Single source
6In 2021, productivity losses from diabetes amounted to USD 272 billion globally due to premature mortality and disability
Verified
7Only 1 in 2 people with diabetes receive adequate diagnosis and treatment globally, leading to USD 500 billion in avoidable costs
Verified
8Continuous glucose monitoring (CGM) adoption is under 5% globally outside high-income countries, despite reducing costs by 20%
Verified
9Diabetes management apps reached 100 million users in 2021, potentially saving USD 10 billion in healthcare costs worldwide
Directional
10In low-income countries, diabetes treatment coverage is 12%, compared to 77% in high-income, widening economic gaps
Single source
11Global insulin market value was USD 24 billion in 2021, but affordability issues persist for 4 million type 1 patients
Verified
12Bariatric surgery for diabetes remission costs USD 20,000-50,000 per procedure but saves USD 100,000 long-term globally
Verified
13Diabetes care workforce shortage affects 90% of low-resource countries, costing USD 50 billion in inefficiencies yearly
Verified
14Telemedicine for diabetes reduced hospital visits by 30% in pilots, saving USD 2 billion potentially if scaled globally in 2021
Directional
15Global diabetes health spending hit USD 1 trillion in 2022, 12% of total health expenditure
Single source
16Lost productivity from diabetes totaled USD 300 billion in 2022 due to 460 million YLDs
Verified
17Insulin prices unaffordable for 10% of type 1 patients in LMICs, costing 1-2 years income
Verified
18GLP-1 agonists market grew to USD 20 billion in 2022, but access limited to 20 countries
Verified
19Diabetes foot care costs USD 15-30 billion annually worldwide from 1 million amputations prevented fractionally
Directional
20Only 50% of diabetes patients achieve HbA1c <7%, costing extra USD 200 billion in complications
Single source
21Digital therapeutics for diabetes saved USD 5 billion in pilots across 10 countries in 2022
Verified
22Retinopathy screening coverage <50% globally, leading to USD 50 billion vision loss costs
Verified
23Stem cell therapies for type 1 in trials could save USD 100 billion long-term if scaled
Verified
24Workforce training gap for diabetes educators affects 4 billion people indirectly, USD 40 billion loss
Directional

Treatment and Economics Interpretation

The world is hemorrhaging a trillion dollars a year to manage diabetes, yet it is still tragically cheaper to let half of its patients go untreated than to equitably provide the simple tools and medicines that would save both lives and a fortune.